Wellnest

JULY 18, 2023

It was in 1901 that people got aware when Willem Einthoven, a Dutch physiologist, developed the string galvanometer, a device capable of recording electrical signals from the heart with remarkable precision. His innovation marked a turning point in cardiac history and earned him the Nobel Prize in Physiology or Medicine in 1924.

Electrocardiogram 52

Electrocardiogram Technology Innovation Heart Rhythm 52

DAIC

DECEMBER 22, 2023

SmartPulse is a prospective, single arm, multi-center, clinical evaluation that will enroll approximately 250 patients with paroxysmal AFib in the United States to evaluate the safety and effectiveness of the Dual Energy STSF Catheter. “ The SmartPulse pivotal trial will allow us to learn more about the promise of PFA in paroxysmal AFib.

Atrial Fibrillation 59

Atrial Fibrillation AFIB Ablation Heart Rhythm 59

Vector Remote

APRIL 14, 2023

History & Future of Cardiac Remote Patient Monitoring Healthcare reforms fueled by government legislation and recent technological innovations have propelled cardiac remote patient monitoring to the forefront in the early 2020s, but the history of cardiac remote patient monitoring dates to more than half a century ago.

Pacemaker 52

Pacemaker Technology COVID-19 Arrhythmia 52

DAIC

FEBRUARY 29, 2024

24 and how those may impact clinical practice and patient care in this deep dive clinical trial session. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? Session 104) - What Is Really New in Electrophysiology That Will Change My Practice? ET Murphy Ballroom 4 ACC.24

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

DAIC

JULY 24, 2024

"Our mission to combat complex heart rhythm diseases relies on optimizing interoperability. FDA 510(k) clearance and European CE Mark approval for its innovative products. Volta Medical’s AI solution is designed to assist electrophysiologists in real-time assessment of dispersed electrograms (EGMs). The company has obtained U.S.

Atrial Fibrillation 105

Atrial Fibrillation AFIB Ablation Technology 105

DAIC

FEBRUARY 24, 2025

By enabling the decisive shift from a reactive to a proactive cardiology model, this technology doesnt just improve patient outcomes it is also helping keep cardiovascular care sustainable and affordable. Most powerfully, it does so without requiring more in-office visits, surgical interventions and hospital stays.

Hospital 52

Hospital Cardiovascular Disease Heart Failure Heart Attack 52

DAIC

JANUARY 24, 2024

This sub-study of the National Institutes of Health-sponsored PRIMARY clinical trial is led by Smidt Heart Institute cardiologist and Chair of the Department of Cardiology Christine Albert, MD, MPH. Patients come to us from all over the U.S. We treat the most complex patient cases. and overseas for our expertise.

Bicuspid/Mitral 105

Bicuspid/Mitral Research Heart Valves Cardiac Arrest 105

Cardiometabolic Health Congress

JANUARY 2, 2025

Significance: Landiolol offers a new, highly selective beta-1 blocker for managing abnormally fast heart rhythms, addressing an important need in cardiac health management. Heart rate reduction within 10 minutes : Landiolol: 40%-90%. Studies on Supraventricular Tachycardia : 5 studies , a total of 317 adults.

Coronary Artery Disease 52

Coronary Artery Disease Stent Stents Innovation 52